These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 6251766

  • 1. A comparison of the cardiovascular effects of haloperidol, thioridazine and chlorpromazine HCl.
    Brannan MD, Riggs JJ, Hageman WE, Pruss TP.
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):48-57. PubMed ID: 6251766
    [Abstract] [Full Text] [Related]

  • 2. Effects of some antipsychotic drugs on cardiovascular catecholamine receptors in the rat.
    Cuffí ML, Vila E, Badia A.
    J Auton Pharmacol; 1989 Dec; 9(6):397-409. PubMed ID: 2576023
    [Abstract] [Full Text] [Related]

  • 3. the role of differential blockade of alpha-adrenergic agonists in chlorpromazine-induced hypotension.
    Morgan JP, Van Maanen EF.
    Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):135-44. PubMed ID: 6108744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of drugs used in psychoses on cerebral dopamine metabolism.
    O'Keeffe R, Sharman DF, Vogt M.
    Br J Pharmacol; 1970 Feb; 38(2):287-304. PubMed ID: 4984801
    [Abstract] [Full Text] [Related]

  • 7. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J.
    Pol J Pharmacol Pharm; 1973 Feb; 25(1):41-52. PubMed ID: 4798098
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M, Takasuna K, Yamashita N, Tamura K.
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [Abstract] [Full Text] [Related]

  • 9. Effects of chlorpromazine, thioridazine and haloperidol on adrenergic transmitter mechanisms in man.
    Tuck JR.
    Eur J Clin Pharmacol; 1973 Aug; 6(2):81-7. PubMed ID: 4358728
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic-induced changes in the anxiolytic and myorelaxant properties of diazepam in the rat.
    Taukulis HK, Fillmore MT, Ruggles JL.
    Pharmacol Biochem Behav; 1992 Jan; 41(1):13-21. PubMed ID: 1347171
    [Abstract] [Full Text] [Related]

  • 11. The effects of chlorpromazine and haloperidol on second messenger systems related to adrenergic receptors.
    Nalepa I.
    Pol J Pharmacol; 1993 Jan; 45(4):399-412. PubMed ID: 8118483
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
    Spealman RD, Kelleher RT, Goldberg SR, DeWeese J, Goldberg DM.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):127-34. PubMed ID: 6848739
    [Abstract] [Full Text] [Related]

  • 14. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J.
    Pol J Pharmacol Pharm; 1973 Jan; 25(1):65-83. PubMed ID: 4775865
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estimation of relative antiavoidance activity of depressant drugs in squirrel monkeys.
    Hanson HM, Witoslawski JJ, Campbell EH, Itkin AG.
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):7-16. PubMed ID: 4957465
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of amphetamine induced polysome dissociation by neuroleptic agents in rat brain.
    Widelitz MM, Coryell MR, Avadhani NG.
    Biochem Biophys Res Commun; 1977 Jun 20; 76(4):1223-9. PubMed ID: 901474
    [No Abstract] [Full Text] [Related]

  • 20. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
    Kövér G, Fekete M, Tost H, Szemerédi K.
    Acta Physiol Hung; 1988 Jun 20; 72(3-4):321-33. PubMed ID: 3250211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.